InsidersTradesSigma
Browse the full record of transactions filed by Miyashita Akiko Moni, 董事. Insider active across 1 company, notably Halozyme Therapeutics, INC.. In total, 1 filings have been logged. Activity tracked since 5 May 2022. The latest transaction was filed on 5 May 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Akiko Moni Miyashita is a Board Member at Halozyme Therapeutics, Inc. She plays an essential role in the strategic direction of the company, overseeing operations and contributing to decision-making. Miyashita brings significant expertise in the biopharmaceutical sector, enriching discussions within the board.